J. M. Bertrand-Hardy

Author

Also Known As

J. M. Bertrand-Hardy, J.M. Bertrand-Hardy, JM Bertrand‐Hardy, J‐M Bertrand‐Hardy

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

J. M. Bertrand-Hardy is an author at Boehringer Ingelheim (Germany) specializing in medicine, cardiovascular disease, and stroke.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	3.4K
2	Public Health	3	3	98
3	Neurology	3	3	98
4	Pharmacology	2	2	76
5	Emergency Medicine	1	1	65

J. M. Bertrand-Hardy

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Robert Altman, L Carreras, Rubén Sierra Díaz, Oxford University Research Archive (ORA) (University of Oxford) ThrombosisIschemic StrokeCardiovascular DiseaseMedicineBlood Platelet	1994	3.3K
CARDIAC SAFETY IN THE EUROPEAN STROKE PREVENTION STUDY 2 (ESPS2) HC Diener, Harald Darius, J. M. Bertrand-Hardy, International Journal of Clinical Practice HypertensionHeart FailureCerebrovascular DiseasePharmacotherapyPreventive Cardiology	2001	65
European Stroke Prevention Study 2: Baseline data J. M. Bertrand-Hardy, Luı́s Cunha, C.D. Forbes, Journal of the Neurological Sciences Stroke RehabilitationCardiovascular DiseaseIschemic StrokeMedicineStroke-related Condition	1995	22
DIPYRIDAMOLE MAY BE USED SAFELY IN PATIENTS WITH ISCHAEMIC HEART DISEASE D M Humphreys, Joan Street, Helmut Schumacher, International Journal of Clinical Practice Stress Test AdjunctHypertensionHeart FailureCerebrovascular DiseaseCardiac Adverse Events	2002	11

Page 1